Literature DB >> 2511187

Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with L-[methyl-11C]methionine.

K Kubota1, T Matsuzawa, T Fujiwara, T Sato, M Tada, T Ido, K Ishiwata.   

Abstract

For the evaluation of tumor imaging with L-[methyl-11C]methionine (11C-Met), a basic study on the differentiation of tumor from inflammation with 11C-Met and a comparison of the diagnostic value of the image with that obtained using 67Ga citrate, a conventional scintigraphic agent, are important. 11C-Met accumulations into inflammatory lesions, AH109A tumor and normal tissues of rats were examined by means of a tissue distribution study. Aseptic inflammatory lesions on the back of Donryu rats induced by croton oil and 1.5% carrageenan showed significantly lower accumulations of 11C-Met than the AH109A tumor. Histologically, croton oil induced granulomatous inflammation and carrageenan, acute exudative inflammation. Whole-body autoradiography with 14C-Met, a substitute for 11C-Met, was negative in the carrageenan lesion and showed a slightly increased activity at the periphery of the croton oil lesion, in contrast with the high tumor activity. Whole-body autoradiography with 67Ga citrate was performed to compare the imaging ability with that of 14C-Met; it showed high activities in the tumor, bone, and intestine, and a broad increased activity at the periphery of the croton oil lesion, but was negative in the carrageenan lesion. 11C-Met accumulations in the inflammations were very low and clinical application with positron emission tomography, should be useful for the differential diagnosis of tumor from inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511187      PMCID: PMC5917843          DOI: 10.1111/j.1349-7006.1989.tb01714.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  [Amino acid uptake in brain tumors using positron emission tomography as an indicator for evaluating metabolic activity and malignancy].

Authors:  O Schober; G J Meyer; C Duden; L Lauenstein; J Niggemann; J A Müller; M R Gaab; H Becker; H Dietz; H Hundeshagen
Journal:  Rofo       Date:  1987-11

2.  Tumor scanning with 67Ga citrate.

Authors:  C L Edwards; R L Hayes
Journal:  J Nucl Med       Date:  1969-02       Impact factor: 10.057

Review 3.  Status of gallium-67 in tumor detection.

Authors:  P Hoffer
Journal:  J Nucl Med       Date:  1980-04       Impact factor: 10.057

Review 4.  Gallium: mechanisms.

Authors:  P Hoffer
Journal:  J Nucl Med       Date:  1980-03       Impact factor: 10.057

Review 5.  Gallium and infection.

Authors:  P Hoffer
Journal:  J Nucl Med       Date:  1980-05       Impact factor: 10.057

6.  Differential diagnosis of solitary pulmonary nodules with positron emission tomography using [11C]L-methionine.

Authors:  K Kubota; T Matsuzawa; T Fujiwara; Y Abe; M Ito; J Hatazawa; T Ido; K Ishiwata; S Watanuki
Journal:  J Comput Assist Tomogr       Date:  1988 Sep-Oct       Impact factor: 1.826

Review 7.  Mechanism of gallium-67 accumulation in tumors.

Authors:  M F Tsan; U Scheffel
Journal:  J Nucl Med       Date:  1986-07       Impact factor: 10.057

Review 8.  The role of gallium-67 in the clinical evaluation of cancer.

Authors:  C Bekerman; P B Hoffer; J D Bitran
Journal:  Semin Nucl Med       Date:  1984-10       Impact factor: 4.446

9.  Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.

Authors:  Y Abe; H Fukuda; K Ishiwata; S Yoshioka; K Yamada; S Endo; K Kubota; T Sato; T Matsuzawa; T Takahashi; T Ido
Journal:  Eur J Nucl Med       Date:  1983

10.  Increased uptake of amino acids and 2-deoxy-D-glucose by virus-transformed cells in culture.

Authors:  K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

View more
  6 in total

Review 1.  Positron emission tomography (PET): expanding the horizons of oncology drug development.

Authors:  Lisa A Hammond; Louis Denis; Umber Salman; Paul Jerabek; Charles R Thomas; John G Kuhn
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

2.  Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET.

Authors:  Songji Zhao; Yuji Kuge; Min Yi; Yan Zhao; Toshiyuki Hatano; Keiichi Magota; Ken-ichi Nishijima; Masashi Kohanawa; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

3.  O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine.

Authors:  Gengo Yamaura; Takashi Yoshioka; Hiroshi Fukuda; Keichiro Yamaguchi; Manami Suzuki; Shozo Furumoto; Ren Iwata; Chikashi Ishioka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

4.  Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.

Authors:  Barbara Stöber; Ursula Tanase; Michael Herz; Christof Seidl; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-08       Impact factor: 9.236

Review 5.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

Review 6.  Imaging and cancer: a review.

Authors:  Leonard Fass
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 7.449

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.